When Lightning Strikes: Fulminant Myocarditis in the Realm of Inflammatory Cardiomyopathies

Circulation

Volumn 136, Issue 6, 2017, Pages 546-548

  Cooper, Leslie T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Editorials; heart failure; myocarditis

Indexed keywords

INOTROPIC AGENT;

ASSISTED CIRCULATION; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; EDITORIAL; FULMINANT MYOCARDITIS; HEART MUSCLE BIOPSY; HUMAN; INFLAMMATORY INFILTRATE; LYMPHOCYTE; MACROPHAGE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; VIRUS MYOCARDITIS; HEART LEFT VENTRICLE FUNCTION; LIGHTNING; MYOCARDITIS;

CARDIOMYOPATHIES; HUMANS; LIGHTNING; MYOCARDITIS; VENTRICULAR FUNCTION, LEFT;

EID: 85026897202     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.029340     Document Type: Editorial

References (15)

1. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526-1538. doi: 10.1056/NEJMra0800028.
2. Saji T, Matsuura H, Hasegawa K, Nishikawa T, Yamamoto E, Ohki H, Yasukochi S, Arakaki Y, Joo K, Nakazawa M. Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children. Circ J. 2012;76:1222-1228.
3. Davoudi AR, Maleki AR, Beykmohammadi AR, Tayebi A. Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection. Scand J Infect Dis. 2012;44:470-472. doi: 10.3109/00365548.2011.631575.
4. Arsenovic N, Sheehan L, Clark D, Moreira R. Fatal carbamazepine induced fulminant eosinophilic (hypersensitivity) myocarditis: Emphasis on anatomical and histological characteristics, mechanisms and genetics of drug hypersensitivity and differential diagnosis. J Forensic Leg Med. 2010;17:57-61. doi: 10.1016/j.jflm.2009.07.021.
5. Thavendiranathan P, Verhaert D, Kendra KL, Raman SV. Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma. Br J Radiol. 2011;84:e99-e102. doi: 10.1259/bjr/13448473.
6. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991;18:1617-1626.
7. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690-695. doi: 10.1056/NEJM200003093421003.
8. Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone M, Mondino M, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation. 2017;136:529-545. doi: 10.1161/CIRCULATIONAHA.117.026386.
9. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216-2233. doi: 10.1161/CIRCULATIONAHA. 107.186093.
10. Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C; American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation. 2016;134:e579-e646. doi: 10.1161/CIR.0000000000000455.
11. Heymans S, Eriksson U, Lehtonen J, Cooper LT Jr. The quest for new approaches in myocarditis and inflammatory cardiomyopathy. J Am Coll Cardiol. 2016;68:2348-2364. doi: 10.1016/j.jacc.2016.09.937.
12. Nishii M, Inomata T, Takehana H, Takeuchi I, Nakano H, Koitabashi T, Nakahata J, Aoyama N, Izumi T. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol. 2004;44:1292-1297. doi: 10.1016/j.jacc.2004.01.055.
13. Fairweather D, Cooper LT Jr, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38:7-46. doi: 10.1016/j.cpcardiol.2012.07.003.
14. Atluri P, Ullery BW, MacArthur JW, Goldstone AB, Fairman AS, Hiesinger W, Acker MA, Woo YJ. Rapid onset of fulminant myocarditis portends a favourable prognosis and the ability to bridge mechanical circulatory support to recovery. Eur J Cardiothorac Surg. 2013;43:379-382. doi: 10.1093/ejcts/ezs242.
15. Boehmer JP, Starling RC, Cooper LT, Torre-Amione G, Wittstein I, Dec GW, Markham DW, Zucker MJ, Gorcsan J 3rd, McTiernan C, Kip K, McNamara DM; IMAC Investigators. Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy. J Card Fail. 2012;18:755-761. doi: 10.1016/j.cardfail.2012.08.001.